Sunquest Information Systems has acquired the PowerPath anatomic pathology information system from Sweden-based Elekta AB for $33 million USD, it was announced this morning in Europe.
Sunquest President and CEO Richard Atkin said of the acquisition, “Sunquest’s commitment to Anatomic Pathology and serving the pathologist has created a natural fit for PowerPath within the Sunquest solution suite. Together, we will have an increased critical mass and expertise to meet the needs of the pathologist in this important and growing market. I am excited to welcome the PowerPath customers into the Sunquest family.”
Elekta, which markets oncology solutions, acquired PowerPath along with IMPAC Medical Systems in 2005. The product was previously sold by IMPATH and Tamtron.
Elekta President and CEO Tomas Puusepp said, “PowerPath is clearly a leading brand in its sector with an impressive customer list of prestigious institutions. However, the synergies between PowerPath and Elekta have been limited and we expect that PowerPath will have good prospects with Sunquest, given their more complementary business"”
PowerPath is supported by 44 US-based employees. Elekta reports that it generates annual revenue of $12 million and is used by more than 450 facilities worldwide that offer surgical pathology, dermatopathology, cytology, and autopsy services.